信隆健康发布第八届董事会第二次会议决议公告

2026年3月19日，深圳信隆健康产业发展股份有限公司（证券代码：002105，以下简称“信隆健康”或“公司”）公布了第八届董事会第二次会议的决议。会议于2026年3月17日在公司办公楼召开，全体11名董事均出席会议，会议决议内容或将对公司未来经营和股价产生重要影响，值得投资者高度关注。

一、继续开展不超过1,500万美元远期外汇交易

• 全体董事审议并通过了《关于2026年继续开展远期外汇交易的议案》。公司将在董事会批准之日起12个月内，与境内外商业银行进行总额不超过1,500万美元的远期结售汇业务。
• 远期外汇交易旨在规避汇率波动风险，增强公司经营稳定性。相关业务将依照公司《远期外汇交易业务内部控制制度》严格执行。
• 该议案的通过有助于公司锁定未来汇率成本，降低财务风险，具有一定的业绩保障作用，对股东权益具有正面影响。

二、为天津信隆实业有限公司提供高达2.6亿元人民币的连带责任担保

• 董事会全体同意为公司全资子公司天津信隆实业有限公司2026年度向九家银行（台湾土地银行、建设银行、民生银行、兴业银行、永丰银行、招商银行、上海商业储蓄银行、北京银行、渤海银行）申请总计最高2.6亿元人民币的融资额度，提供100%连带责任保证。
• 截至2025年12月31日，天津信隆未经审计的资产负债率高达68.28%，此次担保额度巨大，可能对公司整体财务状况和风险水平带来影响。
• 本议案无需提交股东大会审议，由董事会通过并授权董事长廖学金签署相关最高额保证合同等法律文件。
• 大量对外担保事项属于高度关注事项，若出现被担保方资金链波动或履约风险，将直接影响母公司财务安全，投资者应密切跟踪相关进展。

三、修订董事及高管薪酬制度，强化激励机制

• 会议全票通过《关于修订公司<董事、高级管理人员薪酬制度>的议案》，修订后的薪酬制度全文已在巨潮资讯网公开披露。
• 该薪酬制度修订需提交公司股东大会审议。修订内容有望进一步优化公司治理结构，提升董事及高管团队的积极性，助力公司长远发展。
• 激励机制的优化如果显著提升管理层动力，则有潜在业绩改善预期，值得投资人关注股东大会表决结果及后续实施细则。

四、其他事项

• 本次会议决议真实性、准确性及完整性由全体董事会成员担保，相关公告及附件材料已在指定媒体巨潮资讯网和《证券时报》同步披露，符合监管要求。

投资者须知及潜在影响

• 本次会议涉及的远期外汇交易、重大对外担保以及高管薪酬制度修订，均为影响公司经营和财务状况的重大事项。
• 特别是对外连带责任担保金额大，若出现风险事件，将直接影响母公司资产安全和未来利润，属于可能影响股价的敏感事项。
• 外汇套保和薪酬激励制度的调整则有机会带来经营和治理结构的优化，正面影响公司价值。

免责声明：本报道仅供参考，不构成任何投资建议。投资者应审慎评估相关公告内容及公司财务状况，自行承担投资风险。

English Version

Shenzhen XINLONG Health Announces Important Board Meeting Resolutions

On March 19, 2026, Shenzhen XINLONG Health Industry Development Co., Ltd. (stock code: 002105, “XINLONG Health” or “the Company”) released the resolutions of its 8th Board of Directors’ 2nd meeting. The meeting was held on March 17, 2026, with all 11 directors present. The decisions made could significantly impact the company’s operations and share price, and are of high relevance for investors.

1. Continuing Forward Forex Transactions up to USD 15 Million

• The Board unanimously approved the proposal to continue forward forex transactions in 2026. The company is authorized to conduct up to USD 15 million in forward foreign exchange settlements over the 12 months following approval, working with both domestic and foreign banks.
• This measure is designed to hedge against exchange rate volatility, enhancing operational stability. All transactions will strictly follow the company’s internal controls for forex trading.
• This decision helps lock in future forex costs, reducing financial risk, and could positively affect shareholder value by providing earnings stability.

2. Providing CNY 260 Million Guarantee for Subsidiary Tianjin XINLONG Industrial Co., Ltd.

• The Board approved providing a 100% joint liability guarantee for up to CNY 260 million in financing for Tianjin XINLONG Industrial Co., Ltd., a wholly-owned subsidiary, from nine banks (including Land Bank of Taiwan, CCB, CMBC, CIB, E.SUN Bank, CMB, Shanghai Commercial Savings, Bank of Beijing, and Bohai Bank) in 2026.
• As of December 31, 2025, Tianjin XINLONG’s unaudited asset-liability ratio was 68.28%. The large guarantee amount could impact the parent company’s financial position and risk exposure.
• This resolution does not require shareholder meeting approval but was passed by the Board and authorizes Chairman Liao Xuejin to sign all related contracts.
• Such a significant guarantee is a critical matter. If the subsidiary encounters financial stress or default risk, it will directly impact the parent company’s financial security. Investors should closely monitor this development.

3. Revision of Directors and Senior Management Compensation System

• The Board unanimously approved the revision of the “Directors and Senior Management Compensation System.” The full revised text has been published on cninfo.com.cn.
• This proposal requires shareholder meeting approval. The revision aims to optimize the company’s governance structure and strengthen management incentives, supporting long-term development.
• If the new incentive structure significantly boosts management’s motivation, it could improve performance and is worth investor attention regarding the upcoming shareholder vote and implementation details.

4. Other Matters

• The authenticity, accuracy, and completeness of these resolutions are guaranteed by all directors. All related announcements and attachments have been published on official media, meeting regulatory requirements.

Investor Takeaway & Potential Impact

• These decisions on forex transactions, major guarantees, and compensation restructuring are all significant and could impact XINLONG Health’s future operations and financial position.
• Especially, the massive joint liability guarantee for the subsidiary presents a potential risk factor that may affect the parent company’s assets and profits, thus being price-sensitive.
• On the other hand, forex hedging and improved incentive mechanisms may support business and governance improvements, providing a positive outlook for company value.

Disclaimer: This report is for reference only and does not constitute investment advice. Investors should carefully evaluate the official announcements and the company’s financial standing and bear their own investment risks.

View 信隆健康 Historical chart here